These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 2344209

  • 1. Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis.
    Bensouyad A, Hollander AP, Dularay B, Bedwell AE, Cooper RA, Hutton CW, Dieppe PA, Elson CJ.
    Ann Rheum Dis; 1990 May; 49(5):301-7. PubMed ID: 2344209
    [Abstract] [Full Text] [Related]

  • 2. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
    Bedwell AE, Elson CJ, Carter SD, Dieppe PA, Hutton CW, Czudek R.
    Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intrasynovial levels of sulphated glycosaminoglycans and autoantibodies to type II collagen in rheumatoid arthritis: a correlative analysis.
    Karopoulos C, Rowley MJ, Handley CJ.
    Rheumatol Int; 1993 Jan; 13(1):15-20. PubMed ID: 8516619
    [Abstract] [Full Text] [Related]

  • 5. Oxidative response of polymorphonuclear leucocytes to synovial fluids from patients with rheumatoid arthritis.
    Dularay B, Badesha JS, Dieppe PA, Elson CJ.
    Ann Rheum Dis; 1990 Sep; 49(9):661-4. PubMed ID: 2173500
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions.
    Saxne T, Heinegård D.
    Arthritis Rheum; 1992 Apr; 35(4):385-90. PubMed ID: 1373620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human cartilage is degraded by rheumatoid arthritis synovial fluid but not by recombinant cytokines in vitro.
    Hollander AP, Atkins RM, Eastwood DM, Dieppe PA, Elson CJ.
    Clin Exp Immunol; 1991 Jan; 83(1):52-7. PubMed ID: 1988232
    [Abstract] [Full Text] [Related]

  • 10. Correlation of metal-binding proteins and proteinase inhibitors with immunological parameters in rheumatoid synovial fluids.
    Ahmadzadeh N, Shingu M, Nobunaga M, Yasuda M.
    Clin Exp Rheumatol; 1990 Jan; 8(6):547-51. PubMed ID: 1705187
    [Abstract] [Full Text] [Related]

  • 11. Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention.
    Bell MC, Carroll GJ.
    J Rheumatol; 2000 Feb; 27(2):332-8. PubMed ID: 10685793
    [Abstract] [Full Text] [Related]

  • 12. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints.
    Endo H, Akahoshi T, Takagishi K, Kashiwazaki S, Matsushima K.
    Lymphokine Cytokine Res; 1991 Aug; 10(4):245-52. PubMed ID: 1932367
    [Abstract] [Full Text] [Related]

  • 13. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ, Carter SD, Cottrell BJ, Scott DG, Bacon PA, Wallington TB.
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation.
    Dingle JT, Page Thomas DP, Hazleman B.
    Int J Tissue React; 1987 Feb; 9(4):349-54. PubMed ID: 3497901
    [Abstract] [Full Text] [Related]

  • 16. Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis.
    Caccavo D, Sebastiani GD, Di Monaco C, Guido F, Galeazzi M, Ferri GM, Bonomo L, Afeltra A.
    Int J Clin Lab Res; 1999 Feb; 29(1):30-5. PubMed ID: 10356661
    [Abstract] [Full Text] [Related]

  • 17. Bone resorbing activity in synovial fluids in destructive osteoarthritis and rheumatoid arthritis.
    Alwan WH, Dieppe PA, Elson CJ, Bradfield JW.
    Ann Rheum Dis; 1988 Mar; 47(3):198-205. PubMed ID: 3258503
    [Abstract] [Full Text] [Related]

  • 18. Degradation of human cartilage by synovial fluid but not cytokines in vitro.
    Hollander AP, Atkins RM, Eastwood DM, Dieppe PA, Elson CJ.
    Ann Rheum Dis; 1991 Jan; 50(1):57-8. PubMed ID: 1994871
    [Abstract] [Full Text] [Related]

  • 19. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE, Tetlow LC.
    Arthritis Res; 2000 Jan; 2(1):65-74. PubMed ID: 11219391
    [Abstract] [Full Text] [Related]

  • 20. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
    Yukioka K, Inaba M, Furumitsu Y, Yukioka M, Nishino T, Goto H, Nishizawa Y, Morii H.
    J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.